Found 35 matching trials
Expanded Access Study for Renal Transplant Patients With Envarsus XR ™
N/AOpen label, multi-center, expanded access study for renal transplant patien...
Status
Approved For Marketing
Location
Multiple Locations
Pulse Wave Velocity, Tacrolimus Time in Therapeutic Range and CV in African American Kidney Transplants
PHASE4The primary purpose of this study is to evaluate the pulse wave velocity an...
Status
Active Not Recruiting
Location
Hospital of the University of Pennsylvania
Drug Interaction With Envarsus XR and Grapefruit Juice
N/ATransplant patients must take lifelong immunosuppression in order to preven...
Location
UC San Diego Health
Pilot Study of Treatment for Subclinical AMR (Antibody-mediated Rejection) in Kidney Transplant Recipients
EARLY_PHASE1This is a pilot study to determine if extended release Envarsus at an optim...
Location
University of Colorado Anschutz Medical Campus
Islet Transplantation With Recipient T-Reg Cells or Deceased Donor Vertebral Bone Marrow Therapy
PHASE1The goal of this clinical trial is to learn if patients who have brittle ty...
Status
Enrolling By Invitation
Location
Stanford University
Evaluation of Anti-rejection Drug, Tacrolimus, in African-Americans With Kidney Transplant
PHASE4In spite of conventional immunosuppression with lymphocyte-depleting induct...
Status
Active Not Recruiting
Location
Multiple Locations
Comparing Cyclophosphamide and Abatacept With Standard of Care Treatment Following Stem Cell Transplantation
PHASE2The purpose of this study is to investigate whether the combination of cycl...
Location
UC San Diego Moores Cancer Center
Neurocognitive Function Changes With Extended-Release Tacrolimus Among Older Kidney Transplant Recipients
PHASE4The objective of this randomized controlled study is to assess the neurocog...
Location
MGH Kidney Transplant Clinic
Efficacy of Envarsus XR and Digital Health Technology in Reducing Tacrolimus Fluctuation and Frequency of Dose Changes
NATacrolimus is an immunosuppressive agent prescribed to prevent organ reject...
Location
Multiple Locations
Evaluation of the Benefits of Administering Immunosuppressive Drugs as Single Daily Doses Over the First Year After Liver Transplantation (EASY)
PHASE4World Health Organization considers non-adherence has a strong negative imp...
Location
CHU de Besançon - Hôpital Jean Minjoz